Tolerability and Safety of BDB-001 Injection in Healthy Subjects
Clinical trial NCT05361005 · COMPLETED
Trial details
- NCT number
- NCT05361005
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-12
- Primary completion
- 2020-05-08
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.